WHO has listed an additional TB test

The World Health Organization (WHO) has prequalified the Xpert MTB/XDR test, a quality-assured molecular diagnostic tool that enables rapid drug susceptibility testing (DST) for tuberculosis (TB). When used alongside the frontline Xpert MTB/RIF Ultra, this test detects resistance to:

• Isoniazid (INH)

• Fluoroquinolones (FLQ)

• Second-line injectable drugs (SLIDs)

• Ethionamide (ETH)

Related link: Xpert MTB/XDR